Evidence mapPaperPMID 41311465Full record

ArticleResearch (Washington, D.C.)2025

Cabbage Exosome-Like Nanoparticles Encapsulating Small Noncoding tsRNA Prevent Postinjury Arterial Restenosis.

Xiangyu Liu, Xinxing Wang, Jian Li, Zhongjie Zhao, Yan Liu, Xiaolu Li, Wentao Wang, Qianqian Wang, Xiaozhi Sun, Mingjin Guo and 2 more

Abstract read
In one paragraph

Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiangyu LiuDepartment of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Xinxing WangDepartment of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Jian LiDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Zhongjie ZhaoDepartment of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Yan LiuInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266021, Shandong, People's Republic of China.
Xiaolu LiInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266021, Shandong, People's Republic of China.
Wentao WangInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266021, Shandong, People's Republic of China.
Qianqian WangDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Xiaozhi SunDepartment of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Mingjin GuoDepartment of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.
Tao YuInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266021, Shandong, People's Republic of China.ORCID https://orcid.org/0000-0002-0925-2242
Yongxin LiDepartment of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postinjury restenosis is a common complication of peripheral arterial disease treated via endovascular techniques. Its pathogenesis mainly involves neointimal hyperplasia and persistent inflammation. Although antiproliferative drugs used clinically can temporarily slow restenosis, their effects are limited by short action duration and lack of precise regulation. In this investigation, tRF-49:69-chrM.Trp-TCA (tRF-Trp-TCA) was identified through sequencing data from an animal restenosis model, and its regulatory effects on endothelial cell migration and inflammation were confirmed. Additionally, we discovered that cabbage exosome-like nanoparticles (CELNs) could precisely target injured blood vessels in vivo, enhance the stability of nucleic acid therapeutics, and more effectively inhibit neointimal hyperplasia in a carotid artery balloon injury model. Our results demonstrated that tRF-Trp-TCA is crucial in restenosis induced by arterial injury and CELNs loaded with tRF-Trp-TCA effectively inhibit neointimal hyperplasia following carotid artery injury in rats, showing good biocompatibility. This study has, for the first time, identified the target tRF-Trp-TCA for treating restenosis after vascular injury and has also, for the first time, used CELNs as the delivery system. This discovery could provide new insights for noninvasive treatments or mitigation of restenosis post-endovascular therapy.

Identifiers

PMID41311465
PMCPMC12648583

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.